Botanical species · safety record

Dimorphandra mollis

The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Dimorphandra mollis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dimorphandra mollis Benth.

6Constituent measurements

2Safety records

3Cited sources

9Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 9 licensed products naming Dimorphandra mollis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Bean
Dimorphandra mollis
Fruit
Fruit(s)
Pod
Pods
Vegetable
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallic acid	Leaves	Solvent extraction	51.6 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Gallic acid	Bark	Solvent extraction	36.9 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Gallic acid	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Gallic acid	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Proanthocyanidins (condensed tannins)	Bark	Solvent extraction	269.7 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Proanthocyanidins (condensed tannins)	Leaves	Solvent extraction	33 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Nephrotoxicity	Urogenital	—	—	Cattle (as animal)	Case report	No resolvable identifier
Reproductive	Urogenital	Seed	—	Cattle (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Costa, A.M.D., De Souza, D.P.M., Cavalcante, T.V., De Ara�jo, V.L., Ramos, A.T., Maruo, V.M. Poisonous plants of livestock interest in the Amazonia and Savanna ecotone region Part II: Aragua�na, North of Tocantins state, Brazil Plantas t�xicas de interesse pecu�rio em regi�o de ec�tono amaz�nia e cerrado. parte ii: aragua�na, norte do tocantins . Acta veterinaria brasilica, 2011, vol. 5, no. 3, p. 317-324.
Santos, SC., Costa, WF., Ribeiro, JP., Guimaraes, DO., Ferri, PH., Ferreira, HD., Seraphin, JC. Tannin composition of barbatimao species. Fitoterapia, 2002, vol. 73, no. 4, p. 292-299. DOI
Ferreira de Sant'Ana, Fabiano Jose., Reis Junior, Janildo Ludolf., Freitas Neto, Argemiro Pereira., Moreira Junior, Carlos Alberto., Scalla Vulcani, Valcinir Aloisio., Rabelo, Rogerio Elias., Terra, Juliano Pereira. Toxic plants for ruminants in Southwestern Goias, Brazil. Ciencia rural, 2014, vol. 44, no. 5, p. 865-871.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature